SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 353 filers reported holding SALIX PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 1.50 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $125,537,000 | -33.4% | 726,443 | -55.7% | 0.05% | -32.9% |
| Q4 2014 | $188,361,000 | +63.6% | 1,638,780 | +122.4% | 0.07% | +58.7% |
| Q3 2014 | $115,122,000 | +26.4% | 736,825 | -0.2% | 0.05% | +27.8% |
| Q2 2014 | $91,095,000 | -14.8% | 738,509 | -28.4% | 0.04% | -16.3% |
| Q1 2014 | $106,883,000 | +18.6% | 1,031,592 | +2.9% | 0.04% | +19.4% |
| Q4 2013 | $90,142,000 | +39.3% | 1,002,243 | +3.6% | 0.04% | +28.6% |
| Q3 2013 | $64,727,000 | -5.3% | 967,803 | -6.3% | 0.03% | -12.5% |
| Q2 2013 | $68,325,000 | – | 1,032,877 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $46,872,000 | 24.29% |
| HealthCor Management, L.P. | 935,100 | $146,100,000 | 7.50% |
| 1492 Capital Management LLC | 70,167 | $10,963,000 | 6.07% |
| Visium Asset Management, LP | 2,301,629 | $359,607,000 | 5.31% |
| HWG Holdings LP | 39,621 | $6,190,000 | 4.97% |
| Riggs Asset Managment Co. Inc. | 45,649 | $7,132,000 | 4.14% |
| Cardinal Capital Management | 49,139 | $7,677,000 | 3.65% |
| AMI ASSET MANAGEMENT CORP | 213,398 | $33,341,000 | 3.27% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 88,435 | $13,817,000 | 3.14% |
| Adamant Biomedical Investments AG | 78,210 | $12,220,000 | 3.05% |